Libra Therapeutics’ $29 Million Series A Financing

Ambrogio Visconti North America, North America Legal Chronicle

Wilson Sonsini Goodrich & Rosati advised Libra Therapeutics on the deal. Libra Therapeutics launched to develop novel drug candidates focused on restoring the cellular balance lost…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Ambrogio Visconti

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here